HOMOCYSTEINE in lung cancer

• Research type

  Research Study

• Full title

  PROSPECTIVE EVALUATION OF THE ROLE OF HOMOCYSTEINE LEVELS IN BLOOD AS A PREDICTIVE BIOMARKER OF TOXICITY AND AS A PROGNOSTIC BIOMARKER IN LUNG CANCER AND MESOTHELIOMA PATIENTS RECEIVING VITAMIN B12 AND FOLATE SUPPLEMENTATION WITH CHEMOTHERAPY – a prospective observational study

• IRAS ID

  134708

• Contact name

  Mary O'Brien

• Contact email

  Mary.obrien@rmh.nhs.uk

• Sponsor organisation

  The Royal Marsden NHS Foundation Trust

• REC name

  Wales REC 4

• REC reference

  13/WA/0356

• Date of REC Opinion

  31 Oct 2013

• REC opinion

  Favourable Opinion